These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 9886683
1. Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated. Kennett GA, Trail B, Bright F. Neuropharmacology; 1998 Dec; 37(12):1603-10. PubMed ID: 9886683 [Abstract] [Full Text] [Related]
2. Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety. Kennett GA, Bright F, Trail B, Baxter GS, Blackburn TP. Br J Pharmacol; 1996 Apr; 117(7):1443-8. PubMed ID: 8730737 [Abstract] [Full Text] [Related]
4. Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis. Dekeyne A, Girardon S, Millan MJ. Neuropharmacology; 1999 Mar; 38(3):415-23. PubMed ID: 10219979 [Abstract] [Full Text] [Related]
5. SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP. Neuropharmacology; 1997 Mar; 36(4-5):609-20. PubMed ID: 9225286 [Abstract] [Full Text] [Related]
6. Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat. Duxon MS, Kennett GA, Lightowler S, Blackburn TP, Fone KC. Neuropharmacology; 1997 Mar; 36(4-5):601-8. PubMed ID: 9225285 [Abstract] [Full Text] [Related]
7. In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties. Kennett GA, Wood MD, Bright F, Cilia J, Piper DC, Gager T, Thomas D, Baxter GS, Forbes IT, Ham P, Blackburn TP. Br J Pharmacol; 1996 Feb; 117(3):427-434. PubMed ID: 8821530 [Abstract] [Full Text] [Related]
8. 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists. Millan MJ, Peglion JL, Lavielle G, Perrin-Monneyron S. Eur J Pharmacol; 1997 Apr 23; 325(1):9-12. PubMed ID: 9151932 [Abstract] [Full Text] [Related]
11. In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist. Kennett GA, Wood MD, Glen A, Grewal S, Forbes I, Gadre A, Blackburn TP. Br J Pharmacol; 1994 Mar 23; 111(3):797-802. PubMed ID: 7912626 [Abstract] [Full Text] [Related]
14. A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats. Overstreet DH, Knapp DJ, Moy SS, Breese GR. Psychopharmacology (Berl); 2003 Jun 23; 167(4):344-52. PubMed ID: 12677355 [Abstract] [Full Text] [Related]
16. Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety. Nic Dhonnchadha BA, Bourin M, Hascoët M. Behav Brain Res; 2003 Mar 18; 140(1-2):203-14. PubMed ID: 12644293 [Abstract] [Full Text] [Related]
18. Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats. Calama E, Morán A, Ortiz de Urbina AV, Martín ML, San Román L. Pharmacology; 2004 Jun 18; 71(2):66-72. PubMed ID: 15118345 [Abstract] [Full Text] [Related]
19. Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test. Nic Dhonnchadha BA, Ripoll N, Clénet F, Hascoët M, Bourin M. Psychopharmacology (Berl); 2005 May 18; 179(2):418-29. PubMed ID: 15821956 [Abstract] [Full Text] [Related]
20. Mediation by 5-hydroxytryptamine2B receptors of endothelium-dependent relaxation in rat jugular vein. Ellis ES, Byrne C, Murphy OE, Tilford NS, Baxter GS. Br J Pharmacol; 1995 Jan 18; 114(2):400-4. PubMed ID: 7881740 [Abstract] [Full Text] [Related] Page: [Next] [New Search]